Isoprostanes: Free radical-generated prostaglandins with constrictor effects on cerebral arterioles

Stroke

Volumn 28, Issue 4, 1997, Pages 844-849

  Hoffman, Stuart W ^a   Moore, Sandra ^b   Ellis, Earl F ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

brain injuries; cerebral circulation; cerebral ischemia; lipid peroxidation; oxygen radical; rats

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; FREE RADICAL; OXYGEN RADICAL; PROSTAGLANDIN; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN F2 ALPHA DERIVATIVE; PROSTAGLANDIN H2; PROSTAGLANDIN RECEPTOR; PROSTANOID; THROMBOXANE A2 RECEPTOR;

ANIMAL EXPERIMENT; ARTERY DIAMETER; ARTICLE; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TOPICAL DRUG ADMINISTRATION; VASOCONSTRICTION;

EID: 0030932637     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.4.844     Document Type: Article

References (39)

1. Smith DH, Casey K, McIntosh TK. Pharmacologic therapy for traumatic brain injury: experimental approaches. New Horizons. 1995;3:562-572.
2. Caron MJ, Hovda DA, Becker DP. Changes in the treatment of head injury. Neurosurg Clin N Am. 1991;2:483-491.
3. Hall ED, Andrus PK, Yonkers PA, Smith SL, Zhang JR, Taylor BM, Sun FF. Generation and detection of hydroxyl radical following experimental head injury. Ann N Y Acad Sci. 1994;738:15-24.
4. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59:1609-1623.
5. Hall ED, Andrus PK, Yonkers PA. Brain hydroxyl radical generation in acute experimental head injury. J Neurochem. 1993;60: 588-594.
6. Gaetani P, Rodriguez y Baena R, Quaglini S, Bellazzi R, Cafe C, Torri C, Marzatico F. Experimental subarachnoid hemorrhage: events related to anti-oxidant enzymatic systems and eicosanoid peroxide enhancement. Neurochem Res. 1994;19:839-844.
7. Fukunaga M, Makita N, Roberts U, Takahashi K, Badr KF. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 1993;264:C1619-C1624.
8. Fukunaga M, Takahashi K, Badr KF. Vascular smooth muscle actions and receptor interactions of 8-iso-prostaglandin E2, an E2-isoprostane. Biochem Biophys Res Commun. 1993;195:507-515.
9. Fukunaga M, Yura T, Badr KF. Stimulatory effect of 8-epi-PGF2 alpha, an F2-isoprostane, on endothelin-1 release. J Cardiovasc Pharmacol. 1995;26:S51-S52.
10. Morrow JD, Minton TA, Roberts LJ. The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/ endoperoxide receptor antagonist. Prostaglandins. 1992;44: 155-163.
11. Muir JK, Tynan M, Caldwell R, Ellis EF. Superoxide dismutase improves post-traumatic cortical blood flow in rats. J Neurotrauma. 1995;12:179-188.
12. Awad JA, Morrow JD, Takahashi K, Roberts LJ. Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J Biol Chem. 1993;268:4161-4169.
13. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA. 1992;89:1072-10725.
14. Roberts LJ, Morrow JD. The isoprostanes: novel markers of lipid peroxidation and potential mediators of oxidant injury. Adv Prostaglandin Thromboxane Leukot Res. 1995;23:219-224.
15. Morrow JD, Minton TA, Mukundan CR, Campbell MD, Zackert WE, Daniel VC, Badr KF, Blair IA, Roberts LJ. Free radical-induced generation of isoprostanes in vivo: evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem. 1994;269: 4317-4326.
16. Morrow JD, Roberts LJ. The isoprostanes: current knowledge and directions for future research. Biochem Pharmacol. 1996;51:1-9.
17. Hoffman SW, Roof RL, Stein DG. A reliable and sensitive enzyme immunoassay method for measuring 8-isoprostaglandin F2a: a marker for lipid peroxidation after experimental brain injury. J Neurosci Methods. 1996;68:133-136.
18. Longmire AW, Roberts LJ, Morrow JD. Actions of the E2-isoprostane, 8-iso-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. Prostaglandins. 1994;48: 247-256.
19. Moore KP, Darley-Usmar V, Morrow J, Roberts LJ. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res. 1995;77:335-341.
20. McIntosh TK, Smith DH, Meaney DF, Kotapka MJ, Gennarelli TA, Graham DI. Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab Invest. 1996;74:315-342.
21. Muir JK, Boerschel M, Ellis EF. Continuous monitoring of posttraumatic cerebral blood flow using laser-Doppler flowmetry. J Neurotrauma. 1992;9:355-362.
22. Ellis EF, Dodson LY, Police RP. Restoration of cerebrovascular responsiveness to hyperventilation by the oxygen radical scavenger n-acetylcysteine following experimental traumatic brain injury. J Neurosurg. 1991;75:774-779.
23. Fadel MM, Foley PL, Kassell NF, Lee KS. Histidine attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Surg Neurol. 1995;43:52-57.
24. Levasseur JE, Wei EP, Raper AJ, Kontos HA, Patterson JL. Detailed description of a cranial window technique for acute and chronic experiments. Stroke. 1975;6:308-317.
25. Baez S. Recording of microvascular dimensions with an image-splitter television microscope. J Appl Physiol. 1966;21:299-301.
26. White RP, Hagen AA. Cerebrovascular actions of prostaglandins. Pharmacol Ther. 1982;18:313-331.
27. 2α on in vivo cerebral arteriolar diameter in cats and rats. Prostaglandins. 1983;26:917-923.
28. 2α. Stroke. 1975;6:293-297.
29. Mohler ER, Franklin MT, Adam LP. Intracellular signaling by 8-epiprostaglandin F2 alpha is mediated by thromboxane A2/prostaglandin endoperoxide receptors in porcine carotid arteries. Biochem Biophys Res Commun. 1996;225:915-923.
30. Wagerle LC, Busija DW. Effect of thromboxane A2/endoperoxide antagonist SQ 29548 on the contractile response to acetylcholine in newborn piglet cerebral arteries. Circ Res. 1990;66:824-831.
31. 2 in responses of cerebral arterioles during chronic hypertension. Am J Physiol 1992;262:H539-H543.
32. Bouma GJ, Muizelaar JP. Cerebral blood flow, cerebral blood volume, and cerebrovascular reactivity after severe head injury. J Neurotrauma. 1992;9:S333-S348.
33. Bouma GJ, Muizelaar JP, Stringer WA, Choi SC, Fatouros P, Young HF. Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography. J Neurosurg. 1992;77:360-368.
34. Chan KH, Dearden NM, Miller JD. Transcranial Doppler sonography in severe head injury. Acta Neurochir Suppl (Wien). 1993;559:81-85.
35. Schmoker JD, Zhuang J, Shackford SR. Hemorrhagic hypotension after brain injury causes an early and sustained reduction in cerebral oxygen delivery despite normalization of systemic oxygen delivery. J Trauma. 1992;32:714-720.
36. Suzuki S, Ogane K, Souma M, Ohkuma H, Iwabuchi T. Efficacy of steroid hormone in solution for intracranial irrigation during aneurysmal surgery for prevention of the vasospasm syndrome. Acta Neurochir (Wien). 1994;131:184-188.
37. Clark WM, Hazel JS, Coull BM. Lazaroids: CNS pharmacology and current research. Drugs. 1995;50:971-983.
38. 2-isoprostanes during oxidative modification of low density lipoprotein. Biochem Biophys Res Commun. 1994;200:338-343.
39. Meixensberger J. Xenon 133: CBF measurements in severe head injury and subarachnoid haemorrhage. Acta Neurochir Suppl (Wien). 1993;59:28-33.